Showing results (1-10 of 721) with videos related to
Sort By:
Pageof 73
Journal of Hypertension|August 13, 2002
Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertensionGiuseppe Schillaci, Giovanni De Simone, Gianpaolo Reboldi, et al.European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 21, 2008
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)Eva Gerdts, Dana Cramariuc, Giovanni de Simone, et al.The American Journal of Geriatric Cardiology|July 1, 1992
Relation of Age to Left Ventricular Structure, Function, and Systemic Hemodynamics in Normotensive and Hypertensive Employed AdultsHarry A. Aldrich, Mary J. Roman, Giovanni de Simone, et al.American Journal of Hypertension|October 6, 2005
Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI studyGiovanni de Simone, Richard B Devereux, Aldo P Maggioni, et al.Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension StudyEva Gerdts, Peter M Okin, Giovanni de Simone, et al.Hypertension (Dallas, Tex. : 1979)|March 16, 2005
Is high pulse pressure a marker of preclinical cardiovascular disease?Giovanni de Simone, Mary J Roman, Michael H Alderman, et al.Hypertension (Dallas, Tex. : 1979)|February 9, 2005
Association of blood pressure with blood viscosity in american indians: the Strong Heart StudyGiovanni de Simone, Richard B Devereux, Marcello Chinali, et al.The American Journal of Cardiology|February 26, 2014
Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitusGiovanni Cioffi, Andrea Rossi, Giovanni Targher, et al.Journal of Hypertension|May 21, 2010
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension studySilvana Cicala, Giovanni de Simone, Eva Gerdts, et al.Journal of Hypertension|March 11, 2008
Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE studySilvana Cicala, Giovanni de Simone, Kristian Wachtell, et al.Pageof 73